Professor and Chairman, The Department of Health Systems Management, The School of Public Health, The Faculty of Health Sciences and the Guilford-Glazer Faculty of Business and Management at Ben-Gurion University of the Negev, Israel.
Prof. Greenberg teaches on comparative healthcare systems, health technology assessment and management, and economic evaluation of technologies in healthcare.
Since 2008, he is also affiliated with the Center for the Evaluation of Value and Risk in Health (CEVR) at The Institute for Clinical Research and Health Policy Studies at Tufts Medical Center, Boston, MA, and is an adjunct faculty at the Tufts University School of Medicine.
Prof. Greenberg received his doctorate degree from the Ben-Gurion University of the Negev in 2001.
During 2001-2004 he completed a 3-year post-doctoral research fellowship at the Harvard Clinical Research Institute & Cardiovascular Division, Beth Israel Deaconess Medical Center, and Harvard Medical School, initially as a Fulbright Scholar, and was a Visiting Scientist at the Department of Health Policy and Management at the Harvard School of Public Health from 2003-2006.
His research focuses on the economic evaluation of healthcare technologies, health technology policy, diffusion of innovation, medical decision-making and outcomes research. Prof. Greenberg authored or co-authored some 90 papers and book chapters and published his work in leading medical and health policy journals, such as the British Medical Journal, Annals of Internal Medicine, Journal of the National Cancer Institute, Journal of Clinical Oncology, Health Affairs, and Value in Health.
Dan is Associate editor for Value in Health, and Editor-in-chief for Value in Health Regional Issues, the official journals of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Topic editor for Clinical Therapeutics (Pharmacoeconomics, Outcomes, and Health Policy) and member of the editorial board of Applied Health Economics and Health Policy.
He is a member of the board of directors of Clalit, the largest HMO in Israel (4.5 million members), co-founder and the current President of the Israeli Society for Pharmacoeconomics and Outcomes Research (ISPOR-Israel Regional Chapter).